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Abstract
The receptor for advanced glycosylation end products (RAGE) is a multiligand receptor involved in diverse cell signaling pathways.
Previous studies show that this gene expresses several splice variants in human, mouse, and dog. Alternative splicing (AS) plays an
important role in expanding transcriptomic and proteomic diversity, and it has been related to disease. AS is also one of the main
evolutionary mechanisms in mammalian genomes. However, limited information is available regarding the AS of RAGE in a wide
context of mammalian tissues. In this study, we examined in detail the different RAGE mRNAs generated by AS from six mammals,
including two primates (human and monkey), two artiodactyla (cow and pig), and two rodentia (mouse and rat) in 6–18 different
tissues including fetal, adult, and tumor. By nested reverse transcription-polymerase chain reaction (RT-PCR) we identified a high
number of splice variants including noncoding transcripts and predicted coding ones with different potential protein modifications
affecting mainly the transmembrane and ligand-binding domains that could influence their biological function. However, analysis of
RNA-seq data enabled detecting only the most abundant splice variants. More than 80% of the detected RT-PCR variants (87 of 101
transcripts) are novel (different exon/intron structure to the previously described ones), and interestingly, 20–60% of the total
transcripts (depending on the species) are noncoding ones that present tissue specificity. Our results suggest that RAGE undergoes
extensive AS in mammals, with different expression patterns among adult, fetal, and tumor tissues. Moreover, most splice variants
seemtobespecies specific, especially thenoncodingvariants,withonly two (canonical humanTv1-RAGE,andhumanN-truncatedor
Tv10-RAGE) conserved among the six different species. This could indicate a special evolution pattern of this gene at mRNA level.
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Introduction
Nowadays, it is widely known that alternative splicing (AS)
plays an important role in expanding transcriptomic diversity
(Blencowe 2006; Nilsen and Graveley 2010; Mercer et al.
2011), as well as in the generation of proteomic variety,
which has considerable biological consequences (Xing and
Lee 2007; Colak et al. 2013). Recent studies have shown
that in addition to proteins, RNA structure is also involved in
regulating AS (McManus and Graveley 2011; Yang et al.
2011). Both mechanisms as a whole have tissue- or species-
specific functions (Pan et al. 2005; Nurtdinov et al. 2007;
Calarco et al. 2011) and have implications in the generation
of developmental stages (Blencowe 2006; Xing and Lee 2007;
Gingeras 2007; Licatalosi and Darnell 2009). Moreover, AS
seems to be involved in several diseases (Villate et al. 2008;
Irimia and Blencowe 2012; Colak et al. 2013), because it is a
very complex process with several specific splicing site
sequences and many RNA-binding proteins, where mutations
or misregulation may cause disease (Cooper et al. 2009).
It has also been demonstrated that AS is one of the main
evolutionary mechanisms in mammalian genomes (Nurtdinov
et al. 2007; Merkin et al. 2012; Barbosa-Morais et al. 2012).
Diversity in mammalian transcripts seems to be a consequence
of species-specific AS, mainly related to exons conservation
among species (Pan et al. 2005). Furthermore, evidences
of functional selective pressure for AS events have been
GBE
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previously reported (Xing and Lee 2005). However, because
the canonical splice variants carry out critical gene activities,
the minority ones may not often have a major impact on
physiology (Xing and Lee 2005; Blencowe 2006). Therefore,
alternative spliced exons that belong to minority isoforms or
species-specific isoforms seem to evolve more rapidly than
constitutive ones (Xing and Lee 2005). AS has been described
to play an important role in immune system in swine models
(Lynch 2004; Sinkora et al. 2005), and in signal transduction
and susceptibility to diseases in relation with the evolution of
primate species-specific characteristics (Calarco et al. 2007). It
should be taken into account that the majority of these kinds
of analyses have been based on predictive computational
methods and/or in cDNA sequences deposited in different
databases (Pan et al. 2005; Xing and Lee 2005; Nurtdinov
et al. 2007).
In this study, we focus on the receptor for advanced gly-
cosylation end products (RAGE) as a complex spliced gene
in mammals (Yonekura et al. 2003; Hudson et al. 2008;
Kalea et al. 2009; Sterenczak et al. 2009). RAGE (also
termed AGER) is a member of the immunoglobulin (Ig)
superfamily and a cell surface receptor for a broad variety of
ligands including advanced glycation end products (Neeper
et al. 1992), members of the S100/calgranulin superfamily
(Hofmann et al. 1999), amphoterin, also known as HMGB1
(Hori et al. 1995), an amyloidogenic form of serum amyloid A
and beta amyloid (Ab) peptide (Yan et al. 1996). Binding of
these ligands to RAGE entails the activation of diverse signal
transduction pathways implicated in cell growth and prolifer-
ation (Huttunen et al. 1999; Kislinger et al. 1999). The dereg-
ulation of this process seems to be related with several
diseases (Kalea et al. 2011) including diabetes (Goh
and Cooper 2008), immune and inflammatory disorders in
arteriosclerosis (Harja et al. 2008), Alzheimer’s disease
(Ding and Keller 2005a, 2005b; Emanuele et al. 2005), and
invasiveness in various cancers (Hiwatashi et al. 2008;
Ghavami et al. 2008).
Several splice variants of RAGE have been previously
described in human (Malherbe et al. 1999; Yonekura et al.
2003; Ding and Keller 2005b; Hudson et al. 2008), murine
(Kalea et al. 2009), and canine tissues (Sterenczak et al. 2009,
2013). RAGE is composed of three extracellular Ig-like do-
mains: an Ig V-set domain (Ig-V domain) and two Ig C-set
domain (Ig-C domain); and a single transmembrane region
with a short cytoplasmic tail. Splice variants result in changes
that might affect the extracellular ligand-binding domain of
RAGE by different modifications of the region encoding the
Ig-V domain as well as the removal of the sequence encoding
the transmembrane region allowing to generate secreted
RAGE (sRAGE) isoforms (Hudson et al. 2008).
Here we report a deep description of RAGE splice variants
based on experimental data and compared with RNA-seq data
obtained from databases. We have identified by nested
reverse transcription-polymerase chain reaction (RT-PCR)
numerous novel splice variants of RAGE in 6–18 tissues of
six different mammals, and we have performed a wide com-
parison among them. Furthermore, we have performed a de-
tailed analysis of high-throughput RNA sequences (RNA-seq)
from brain and liver samples of five of the six analyzed mam-
mals, which data were obtained from Pan et al. (2008),
Barbosa-Morais et al. (2012), Merkin et al. (2012), and
ENCODE Project. This is the first comparison of RAGE splice
variants among several species within the orders primates,
artiodactyla, and rodentia, and our results suggest a special
evolution pattern of this gene at the mRNA level. Additionally,
we analyzed the relative expression levels of the different
splicing variants in the studied tissues and species, as well
as the relative abundance of coding and noncoding tran-




For the screening of RAGE splice variants, we analyzed mRNAs
from six mammalian species corresponding to different tissues,
including adult, embryonic, and cancer tissues, that were ob-
tained from BioChain through one of their European distribu-
tor “AMS Biotechnology” as follows: human adult (blood,
brain, kidney, liver, lung, pancreas, spleen, and thymus),
fetal (brain, heart, kidney, liver, lung, spleen, and thymus),
and human cancer tissues (kidney, liver, and lung); rhesus
monkey adult tissues (brain, heart, kidney, liver, lung, and pan-
creas); bovine and swine adult tissues (brain, heart, kidney,
liver, lung, and spleen); mouse adult (brain, heart, kidney,
liver, lung, and pancreas) and mouse embryonic tissues (11,
15, and 17 days of development); and rat adult (brain, heart,
kidney, liver, lung, pancreas, and spleen) and rat embryonic
tissues (13 days of development) (for tissue details see supple-
mentary table S1, Supplementary Material online).
Splice Variants Identification
One microgram of total RNA from each tissue was used for
oligo-dT primed cDNA synthesis, which was performed using
the ImProm II Reverse Transcription System (Promega) follow-
ing the manufacturer’s instructions. All cDNAs were checked
by amplification of the housekeeping beta-actin gene expres-
sion as proof of reliable cDNA template, with the following
forward and reverse primers: Actin_F 50CTTCGCGGGCGACG
ATGC30 and Actin_R 50TGGTGGTGAAGCTGTAGCC30.
The splicing isoforms were amplified by nested PCR from
the different tissues cDNAs with GoTaq Green Master Mix
(Promega). The PCR conditions were as follows: 95 C for
5 min followed by 30 cycles of 95 C for 1 min, 60 C for
2 min, 72 C for 2 min, and ending by 72 C for 5 min.
The first round was performed with 1ml of cDNA in a 20ml
reaction volume and with external forward and reverse
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primers (extF and extR) as follows: H. sapiens and M. mulatta
(RAGE_extF 50CAGGACCCTGGAAGGAAGCAGG30 and
RAGE_extR 50CTGGTTGTAGAAGAAAGCTTGGC30), B. taurus
(BtRAGE_extF 50AGCCTGGGAAGGAAGCAGG30 and
BtRAGE_extR 50GGTTGTGGAAGAAAGTTTGGG30), S. scrofa
(SsRAGE_extF 50AGCCTGGGAAGGAAGCAGG30 and
SsRAGE_extR 50GGGTGAACTGGTCTGGGGCC30), and R. nor-
vegicus and Mu. musculus (RnRAGE_extF 50AGCCTGGGAAG
GAAGCACC30 and RnRAGE_extR 50ATCATGTGGGCTCTGGTT
GG30). Primers were designed to amplify from start to stop
codon of the canonical full-length RAGE gene (Hudson et al.
2008). For the second round, we used primers just down-
stream of the first round ones called internal forward and
reverse primers (intF and intR), as follows: H. sapiens and
M. mulatta (RAGE_intF 50AGCCGGAACAGCAGTTGG
AGCC30 and RAGE_intR 50GCCCTCCAGTACTACTCT
CGCC30), B. taurus (BtRAGE_intF 50GGGGCAGTGGTCGGAG
CC30 and BtRAGE_intR 50CTCCTGTGCTGCTCTCTGCC30),
S. scrofa (SsRAGE_intF 50GCAGCAGGGACAACGGCC30 and
SsRAGE_intR 50GCTCCTGCACTGCTCTCAGCC30), and R. nor-
vegicus and Mu. musculus (RnRAGE_intF 50ACAGCAGCTAGA
GCCTGGG30 and RnRAGE_intR 50CCCGGCACCATTCTCTGG
C30). The second round was performed with 1ml of a 1:10
dilution of the first round product as template on a final
volume of 20ml and only 20 cycles. To verify product size
and experimental reproducibility, two independent PCR exper-
iments were performed and loaded on a 2% agarose gel. The
splicing isoforms products were gel purified as single bands,
except from human and rhesus monkey where 1–1.5 kb
bands were extracted at the same time, using the Wizard
SV Gel and PCR Clean up System (Promega), and then
cloned into the pGEM-T Easy vector (Promega). The resultant
plasmids were purified by Wizard Plus SV Minipreps DNA
Purification Systems (Promega) and sequenced using T7 (50T
AATACGACTCACTATAGGG30) and Sp6 (50GATTTAGGTGACA
CTATAGAATAC30) primers by the Genomics Unit at the
Parque Cientı´fico de Madrid (http://www.fpcm.es/, last
accessed December 2, 2013). Relative abundance of each
splice variant was measured as the result of the gel intensity
for each single band using ImageJ software (http://rsb.info.nih.
gov/ij/index.html, last accessed December 2, 2013). In the case
of 1–1.5 kb bands, their relative abundance was related to the
number of colonies found from the 48 total colonies checked
in each tissue and measure as follows: lower than 20% of the
total colonies was considered as low expression, 20–40% as
moderate expression, 40–50% as moderate–high expression,




Sequence data were annotated using the BioEdit software
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html, last accessed
December 2, 2013) and aligned to Tv1-RAGE mRNA (cDNA)
and to genomic RAGE DNA in each species using EBI Pairwise
Alignment (http://www.ebi.ac.uk/Tools/psa/, last accessed
December 2, 2013) to obtain the exonic composition of
each isoform and to compare it to the canonical one. The
translation of each splice variant to protein was performed
using ORF Finder (www.ncbi.nlm.nih.gov/gorf/, last accessed
December 2, 2013). Pfam (http://pfam.sanger.ac.uk/, last
accessed December 2, 2013) was used for general domain
prediction and SignalP4.0 Server (http://www.cbs.dtu.dk/ser-
vices/SignalP/, last accessed December 2, 2013) for signal pep-
tide prediction. Splice variants with less than one protein
domain and one or more premature stop codons (PSC)
were considered as noncoding RNA (ncRNA) variants. mRNA
splice variants were named as Sp_RAGE_VN (where species
was abbreviated by Gsss¼first letter of genus and the three
first letters of the species name, VN¼mRNA variant number).
The sequence data from this study have been submitted to
GenBank with the accession numbers: H. sapiens
(GU139370–84), M. mulatta (GU139408–22), B. taurus
(GU139385–407), S. scrofa (GU164706–14), Mu. musculus
(GU164727–39) and R. norvegicus (GU164715–26) (For de-
tails see supplementary fig. S1, Supplementary Material
online).
RNA-Seq Data Analyses
RNA-seq data from brain and liver tissues of different species
were obtained from the National Center for Biotechnology
Information (NCBI) Sequence Read Archive (SRA) database,
single reads of SRP007412 (Barbosa-Morais et al. 2012)
and paired reads of SRP016501 (Merkin et al. 2012). Paired
reads of human Monocytes-CD14+ from ENCODE project
(SRX179434) were also analyzed. Reads were mapped to
the genome of each species, obtained from the Ensembl
Database (H. sapiens: GRCh37, M. mulatta: MMUL_1,
B. taurus: UMD3.1, Mu. musculus: GRCm38, R. norvegicus:
Rnor_5.0), using the default parameters of TopHat and
Bowtie (Trapnell et al. 2009; Langmead et al. 2009).
Junction reads of the BED files (TopHat outfile) were normal-
ized (per million of mapped reads) to compare splice events
among samples. Samtools software (Li et al. 2009) was used
for indexing BAM files (TopHat outfile), conversing alignment
formats, and sorting the gene region of interest. The resulting
RAGE-aligned reads were used to assemble them into
transcripts using Cufflinks (Trapnell et al. 2010) by both de-
fault (-F 0.1 and -j 0.15) and modified (-F 0 and -j 0.5) param-
eters. Additionally, the experimentally described transcripts
were provided to Cufflinks by a GTF file, and their relative
abundances were estimated. The expression of each transcript
was measured in Fragments Per Kilobase of exon model per
Million mapped fragments. The IGV browser (Robinson et al.
2011) was used for visualization of mapped reads and assem-
bled transcripts to its genome context.
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Results
Primates RAGE Splice Variants
Identification and Characterization of Human RAGE Splice
Variants
To fully characterize H. sapiens RAGE splice variants, we per-
formed specific nested RT-PCR assays in 18 different tissues.
Detailed analyses of these results showed a total of 22 differ-
ent variants obtained from eight adult, seven fetal, and three
tumoral tissues (fig. 1). Interestingly, 15 of these isoforms
were novel RAGE splice variants (different exon/intron struc-
ture to the previously described ones) named HsapRAGEv1 to
v15 (detailed information regarding these novel variants and
the previously described ones is available in supplementary fig.
S1, Supplementary Material online). Transcript variant 1 (also
known as full-length RAGE, and hereafter Tv1-RAGE) was
identified in this study as one of the most abundant splice
variants (fig. 1), in agreement to previous descriptions
(Hudson et al. 2008). This isoform is composed by a signal
peptide encoded within exon 1, an Ig-V domain within exons
2 and 3, two Ig-C domains within exons 4–6 and 7–8, respec-
tively, and a single transmembrane region within exon 10
followed by a short cytoplasmic tail within exon 11 (Hudson
et al. 2008) (fig. 1).
Other found alternative splice variants show changes in
these domains. For instance, intron 1 retention in Tv10-
RAGE (previously named N-truncated) and HsapRAGEv1 to
v8 splice variants results in a PSC, but there is an alternative
downstream potential start codon located at exon 3 exclud-
ing the signal peptide (which could affect to the function-
ality of the protein) and the Ig-V domain from their
potential encoded isoforms (fig. 1). Tv10-RAGE was recently
defined as a noncoding variant by NCBI, although several
authors consider it as a coding isoform that lacks the Ig-V
domain (Yonekura et al. 2003; Sterenczak et al. 2013).
Tv10-RAGE variant only presents this splice event, whereas
HsapRAGEv1 to v8 present a combination of other addi-
tional AS events (fig. 1). Another common splicing event is
the inclusion of part of intron 9 and skipping of exon 10
(Tv6-RAGE or C-truncated, Tv4-RAGE, HsapRAGEv1 to v6,
v8, and v9 splice variants) that results in the loss of the
transmembrane region and cytoplasmic tail and, therefore,
generating potential sRAGE protein isoforms. We have also
found other different splicing events, such as the use of a
different 50-donor splice site in exon 4 (Tv2-RAGE and Tv4-
RAGE, previously described by Hudson et al. 2008), that
would cause variations in the region encoding the
corresponding Ig-C domain and therefore, this could
modify the ligand specificity and/or the binding affinity. In
addition, we found several predicted noncoding short var-
iants (RAGE_v11, HsapRAGEv10 to v15 splice variants),
which present skipping of several exons and use of differ-
ent acceptor splice sites (fig. 1).
We have also assessed the relative abundance of each
splice variant showing differences in expression levels
among all the analyzed tissues. Tv1-RAGE, Tv2-RAGE, and
Tv10-RAGE variants were the most prevalent of the detected
transcripts in the majority of the analyzed tissues. Moreover,
large splice variants with different intron retentions show low
but uniform expression among the different tissues. By con-
trast, small splice variants also show low expression levels but
with a very specific distribution on particular tissues, even
among embryonic or tumoral states within the equivalent
tissue. All the analyzed tissues show this similar pattern of
expression levels, but interestingly we have observed that
adult and fetal lung only express Tv1-RAGE and Tv6-RAGE
(C-truncated) variants at high levels, whereas tumor lung
expresses all the different large splice variants but at low
levels. Nearly 40% of the total analyzed variants in human
are noncoding (fig. 2).
Identification and Characterization of Rhesus Macaque
RAGE Splice Variants
In M. mulatta, we detected in total 15 novel variants of RAGE
within six different adult tissues (fig. 3), and one of them
was the predicted canonical Tv1-RAGE (NM_001205117–
GU139417). We have named these splice variants as
MmulRAGEv1 to v15. Only Tv1-RAGE was previously anno-
tated on databases based on homology to human, but we
show here the first biological evidence for this isoform.
MmulRAGEv5 and Tv1-RAGE from M. mulatta are directly
related to the exon/intron structure of Tv10-RAGE and Tv1-
RAGE human splice variants, respectively. Furthermore,
we found an isoform (MmulRAGEv3) that retains introns 1
and 6 and is related to an isoform (NtRAGE) previously
described in humans (supplementary fig. S1, Supplementary
Material online) and not detected by us, involved in
Alzheimer’s disease (Ding and Keller 2005a, 2005b). None
of the remainder macaque variants have a human homolo-
gous variant (table 1).
Inclusion of intron 1 is shown in MmulRAGEv1 to v5, in
which MmulRAGEv1 is predicted as ncRNAs due to the pres-
ence of different PSC in introns 1 and 6 or exon 7. The whole
inclusion of intron 6 in MmulRAGEv6 and its partial inclusion
in MmulRAGEv9 resulted in the appearance of PSCs. The
potential encoded isoforms of these two variants could
be new sRAGE isoforms lacking also the last IgC domain
(fig. 3). We found changes in the amino acid sequence of
the Ig-V domain in MmulRAGEv11 which turns it into an
Ig-C domain as a result of the use of a 50-donor alternative
splice site in exon 3. Moreover, an alternative 30-acceptor
splice site in exon 2 detected in MmulRAGEv8 transcript
implies changes in the reading phase and, due to that a PSC
appears, although an isoform could be generated from a
downstream start codon in exon 3 (fig. 3). In addition,
we found four smaller isoforms (MmulRAGEv12 to v15),
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which present skipping of large number of exons, one of them
could be a potential coding variant (MmulRAGEv12), whereas
the other three are predicted as ncRNA. Noncoding variants
form around 30% of the total monkey RAGE isoforms (fig. 2).
Macaque tissues show different expression levels of each
variant (fig. 3). Tv1-RAGE, MmulRAGEv8, MmulRGEv5, and
MmulRAGEv3 were the most abundant variants among
different tissues. MmulRAGEv8 is overrepresented in brain,
whereas macaque Tv1-RAGE is overrepresented in lung
tissue, as it happens with its homologous human variant. As
MmulRAGEv8 lacks the IgV domain in relation to Tv1-RAGE,
the overexpression in brain could indicate that MmulRAGEv8
is probably binding to another ligand. However, we have to




























































Ig variable (IgV) domain
Non-coding sequences
Coding sequences
Ig constant (IgC2) domain
Transmembrane region (TM)
Signal peptide (SP)
1 2 3 4 5 6 7 8 9 10 11
Homo sapiens 
SP TM TailIgV IgC2 (1) IgC2 (2)
FIG. 1.—RAGE transcript variants in Homo sapiens. Representation of human RAGE splice variants and their relative expression levels in different
adult (A), fetal (F), and tumor (T) tissues. Potential protein domains are shown with different colors, and noncoding sequences are shown in white.
Junctions from the canonical variant are shown as straight lines, whereas the alternative junctions are shown as open triangles. Splice variants are arranged
by length.
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noncoding variants show low expression levels and are only
present in lung tissue, with the exception of the potential
coding MmulRAGEv12 that it is only expressed in liver.
Artiodactyla RAGE Splice Variants
Identification and Characterization of Bovine RAGE Splice
Variants
In B. taurus we have detected a total of 24 alternative splice
variants of RAGE within six different adult tissues (fig. 4), 23
of them were novel alternative splice variants (named
as BtauRAGEv1 to v23), Tv1-RAGE being the only one previ-
ously described by Neeper et al. (1992) (NM_173982) (supple-
mentary fig. S1, Supplementary Material online). Tv1-RAGE
and BtauRAGEv7 isoforms are related structurally to the
similar human and macaque variants (table 1). However,
BtauRAGEv7 splice variant leads to several changes at protein
level when compared with the primates counterparts, due to
EXPRESSION LEVELS:
Low High Ig variable (IgV) domain
Non-coding sequences
Coding sequences
Ig constant (IgC2) domain
Transmembrane region (TM)
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FIG. 3.—RAGE transcript variants inMacacamulatta. Representation of monkey RAGE splice variants and their relative expression levels in different adult
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FIG. 2.—Relative abundance of coding versus noncoding transcript
analyzed. Stacked percentage bars reflect the portion of previously
described variants and the variants that we found in our study (coding
and noncoding) present in different analyzed species.
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an alternative downstream start codon located at exon 2,
instead of exon 3. Only BtauRAGEv1 and BtauRAGEv2 could
generate N-truncated proteins similar to the human one but,
in this case, due to the retention of introns 1 and 3 or introns 1
and 2, respectively. BtauRAGEv22 is similar to HsapRAGEv14,
being predicted as ncRNAs, and BtauRAGEv3 and v6 have
homologs in macaque (table 1). Furthermore, sRAGE isoforms
could be generated by exon 8 skipping (BtauRAGEv9, v10,
and v13), using alternative donor sites (BtauRAGEv12), or by
intron retention (BtauRAGEv3), but in all these cases lacking
the second Ig-C domain. In addition, several noncoding splice
variants are found with large “deletions” (BtauRAGEv14 to
v23), or small ones and intron retentions (BtauRAGEv5
and v11), which represent around 50% of whole transcripts
(fig. 2).
In relation to relative abundance of each splice variant,
figure 4 shows high and wide expression levels of
BtauRAGEv7 splice variant, whereas the rest of splice variants
show in general low and tissue-specific expression levels. In
contrast to human, bovine Tv1-RAGE presents low expression
levels in the lung tissue.
Identification and Characterization of Swine RAGE Splice
Variants
Sus scrofa only shows 10 alternative splice variants of RAGE
within the six different analyzed adult tissues (fig. 5), becom-
ing the species with fewer variants, even when comparing the
same number and type of tissues. Databases searches only
show the predicted Tv1-RAGE isoform, whereas the rest are
novel alternative splice variants (named SscrRAGEv1 to v9).
Tv1-RAGE and SscrRAGEv5 isoforms are again the only two
variants similar to human splice variants (Tv1-RAGE and Tv10-
RAGE, respectively, table 1), showing the same domains as
the humans counterparts. Retentions of intron 1 and/or 3 are
common events in swine RAGE (SscrRAGEv1 to v7 and v9).
These events result in a PSC and a downstream start codon
located at exon 4, instead of exon 3 in primates or in exon 2 in
B. taurus, which could encode proteins that lack the Ig-V
domain and the signal peptide. SscrRAGEv1 isoform is related
to bovine BtauRAGEv1 isoform with similar protein domains
(table 1). Furthermore, soluble isoforms could also be present
in swine RAGE, as a result of the use of an alternative
30-acceptor splice site in exon 10 (SscrRAGEv7 and v8) and
therefore lacking the transmembrane region. On the other
hand, swine RAGE only shows two predicted noncoding
splice variants (SscrRAGEv2 and v9), representing 20% of all
variants detected (fig. 2).
Expression levels of the different splice variants in swine
(fig. 5) are quite different compared with human ones. In
swine, SscrRAGEv5 isoform, which is equivalent to human
Tv10-RAGE, is also highly and widely expressed in all the
analyzed tissues, even in lung tissue where the human homo-
log is not expressed. However, Tv1-RAGE expression is mod-
erate and only in two tissues (kidney and spleen), remarkably,
there is no Tv1-RAGE expression in lung (fig. 5).
Rodents RAGE Splice Variants
Identification and Characterization of Mouse RAGE Splice
Variants
We detected a total of 17 alternative splice variants of RAGE
from Mu. musculus within different adult and embryonic tis-
sues (fig. 6). Tv1-RAGE was already in databases, and
mRAGE_v2, v4, and v5 were previously described (Kalea
et al. 2009) (supplementary fig. S1, Supplementary Material
online). The other 13 splice variants are novel and named as
MmusRAGEv1 to v13 (fig. 6). Only two of these variants, Tv1-
RAGE and mRAGE_v2 are related, in terms of exon/intron
structure, to the equivalent splice variants in other analyzed
mammalian species (table 1). However, mRAGE_v2 presents
another PSC in exon 5, not present in the other homologs,
and as a result, mRAGE_v2 is a noncoding variant (fig. 6).
There is a potential soluble murine splice variant
Table 1
Conserved RAGE Variants Based on Exon/Intron Composition across Mammals
RAGE splice variants Homo sapiens Macaca mulatta Bos taurus Sus scrofa Mus musculus Rattus norvegicus
Tv1-RAGE MmulRAGEv10 Tv1-RAGE Tv1-RAGE Tv1-RAGE Tv1-RAGE
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(MmusRAGEv5) related to a swine one (SscrRAGEv8) (table 1).
In addition, other potential soluble variants containing the
signal peptide and the first two Ig domains could be generated
(MmusRAGEv2 to v6) (fig. 6), and three by the presence of
stop codons before exon 10 (MmusRAGEv2, v3 and v5).
Harashima et al. (2006) had previously described an isoform
(esRAGE) that could generate soluble proteins (by intron 9
retention), but we have not been able to identify it (supple-
mentary fig. S1, Supplementary Material online). Another
event that could produce domain alterations is present in
MmusRAGEv1 due to the use of an alternative 30-acceptor
splice site in exon 3 and, therefore, removing the Ig-V
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FIG. 4.—RAGE transcript variants in Bos taurus. Representation of bovine RAGE splice variants and their relative expression levels in different adult tissues.
See figure 1 for details. BtauRAGEv7 (bold) is related to the human Tv10-RAGE.
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domain. We found several noncoding splice variants of which
mRAGE_v5 and mRAGE_v2 were previously described, and
MmusRAGEv7 to v13 being novel from this study (supplemen-
tary fig. S1, Supplementary Material online). In total, they
represent more than 50% of murine splice variants (fig. 2).
Relative abundance of each splice variant shows differences
in expression levels among tissues (fig. 6) as well as compared
with other mammals analyzed in this study. Tv1-RAGE
presents, as in humans, high and wide expression, either in
embryonic or adult tissues. Nevertheless, the noncoding
mRAGE_v2 (equivalent in structure to potential coding
human TV10-RAGE) shows low expression levels in brain,
liver, and 11 days embryonic tissue, and only shows moderate
expression levels in pancreas adult tissue, in contrast to the
human homolog which is highly expressed. Other splice
variants show low expression levels but with a specific distri-
bution among tissues and state of development.
Identification and Characterization of Rat RAGE Splice
Variants
We detected a total of 13 alternative splice variants of RAGE
from R. norvegicus within different adult and embryonic
tissues (fig. 7). Tv1-RAGE sequence was previously found
based on homology, whereas the other 12 were novel
alternative splice variants named as RnorRAGEv1 to v12 (see
supplementary fig. S1, Supplementary Material online).
Tv1-RAGE and RnorRAGEv2 isoforms are related to human
splice variants, as well as in the other analyzed species
(table 1). Rat RnorRAGEv2, although related structurally to
human TV10-RAGE, shows changes at protein level being
similar to bovine BtauRAGEv7 isoform, with the Ig-V domain
present (fig. 7).
Intron 1 retention is present in some splice variants
(RnorRAGEv1, v2, v4, and v8) resulting in PSC on the retained
intron, with an alternative downstream start codon located at
exon 2 that conforms potential coding splice variants, and
noncoding splice variant when intron 3 is also retained
(RnorRAGEv1) or due to several exon skipping events
(RnorRAGEv8). Some rat RAGE splice variants are related to
murine RAGE splice variants (table 1), of which RnorRAGEv3
(related to mRAGE_v4) is broadly expressed and quite similar
in protein structure to TV1-RAGE as it only lacks the short
region between the second IgC. Noncoding splice variants
(RnorRAGEv1 and RnorRAGEv6 to v12) represent more than
60% of ncRNA in R. norvegicus (fig. 2).
Relative abundance of each rat splice variant shows differ-
ences in expression levels among tissues, especially noncoding
variants that show specific distribution around tissues and
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FIG. 5.—RAGE transcript variants in Sus scrofa. Representation of porcine RAGE splice variants and their relative expression levels in different adult
tissues. See figure 1 for details. Splice variants are arranged by length. SscrRAGEv5 (bold) is related to the human Tv10-RAGE.
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embryonic developmental stages. Tv1-RAGE presents the
highest expression levels in all tissues, with the exception of
the liver where it is not expressed. Lung tissue shows similar
expression levels to human ones, with high levels of Tv1-RAGE
and low levels of RnorRAGEv3 and smaller noncoding
isoforms. RnorRAGEv1 and RnorRAGEv2 variants show
moderate and moderate–high levels in adult tissues, the last
one in agreement with the human homolog TV10-RAGE. In
embryonic tissue, Tv1-RAGE and RnorRAGEv3 are the most
abundant transcripts (fig. 7).
Identification of RAGE Splice Variants by
High-Throughput Technologies
Nowadays, RNA-seq data are a powerful tool to perform
transcriptional studies, from description of new isoforms to
quantification of all transcripts. For this reason, we decided
to carry out high-throughput RNA analyses of sequencing
data deposited in the SRA database (Pan et al. 2008;
Barbosa-Morais et al. 2012; Merkin et al. 2012) to compare
them with our nested RT-PCR results. We mapped these pub-
lically available RNA-seq reads from brain and liver tissues
to each genome of reference (human, monkey, bovine, rat,
and mouse), and afterward, relative abundances of RT-PCR
detected RAGE transcripts were estimated using Cufflinks.
The analyses confirmed that RAGE is a very lowly expressed
gene due to a minimum or null coverage (supplementary table
S2, Supplementary Material online). In human, Tv1-RAGE
shows moderate expression in brain and Tv10_RAGE in liver,
in accordance with our RT-PCR results. In addition, macaque
MmulRAGEv2 and MmulRAGEv6 variants are the mainly
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FIG. 6.—RAGE transcript variants in Mus musculus. Representation of mouse RAGE splice variants and their relative expression levels in different adult
and embryonic tissues. See figure 1 for details. mRAGE_v2 (bold) is related to the human Tv10-RAGE.
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expressed in brain and liver followed, in brain, by Tv1-RAGE,
which is not expressed in liver. These RNA-seq results are not
in agreement with the RT-PCR ones where MmulRAGEv8 is
more expressed in all tissues followed by Tv1-RAGE. In the
bovine analyses, BtauRAGEv1, v2, and v4 are highly expressed
in brain and BtauRAGEv1 and v3 in liver (with some correlation
to our PCR results). Moreover, bovine Tv1-RAGE is moderately
expressed in brain but not expressed in liver, whereas
BtauRAGEv7, which is very highly detected by PCR, shows
no expression in RNA-seq samples. In mouse RNA-seq sam-
ples, the mainly expressed variants are Tv1-RAGE (as by our
PCR results) and mRAGE_v5 in both tissues. In addition, we
observe similar expression results between both technologies
in Tv1-RAGE, RnorRAGEv1, and v2 rat variants. Nevertheless,
it is important to observe that all expression levels show
extremely low values.
Furthermore, we analyzed data from a human sample
(monocytes) from the ENCODE project with a very high
number of reads. Using default parameters, Cufflinks was
only able to assemble three transcripts (supplementary fig.
S2, Supplementary Material online) which do not correlate
with those we found by nested RT-PCR, even the canonical
transcript could not be assembled. As Cufflinks suppresses the
output of smaller fractions of splice variants, we approached
this analysis altering the parameters which modify the minimal
isoform fraction and the pre-mRNA fraction. As a result,
we were able to assemble Tv1-RAGE, Tv10-RAGE, and
HsapRAGEv8 (supplementary fig. S2, Supplementary
Material online) in the human monocytes sample. We
extended this approach to the previously analyzed brain and
liver samples in all the different species. Tv1-RAGE was
detected in only one brain human sample, and N-truncated-
related variants were assembled in macaque brain
(MmulRAGEv5) and both bovine tissues (BtauRAGEv7).
MmulRAGEv6 was also assembled in macaque brain. (supple-
mentary fig. S2, Supplementary Material online). No variants
could be assembled in the rodent samples.
Observing that Cufflinks analyses were not able to assem-
ble all the isoforms detected by RT-PCR, not even the mainly
expressed ones, we decided to analyze the number of splicing
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FIG. 7.—RAGE transcript variants in Rattus norvegicus. Representation of rat RAGE splice variants and their relative expression levels in different adult and
an embryonic tissue. See figure 1 for details. RnorRAGEv2 (bold) is related to the human Tv10-RAGE.
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events detected by TopHat, by using the reported junctions.
We were able to detect most of the canonical splice events but
only in those samples which have high read coverage. It is
interesting to notice that the splice event between exons 1
and 2 is not present in any bovine sample, in accordance to
our results obtained by RT-PCR. For that reason, we were not
able to assemble the Tv1-RAGE isoform using Cufflinks,
and the equivalent to the human N-truncated variant was
the only isoform assembled in these samples. Moreover, a
few alternative spliced events were also detected in all the
species (supplementary fig. S3, Supplementary Material
online) but all of them with extremely low expression values.
Some of these events showed values between 0.004 and
0.008 junction reads per million of mapped reads, which
correspond to just one or two junctions found in the total
sample. These events show a similar tissue expression pattern
as our experimental results. For instance, partial retention of
intron 6 in rhesus monkey is lowly detected in brain, as the
variants which contain this splice event (MmulRAGEv5, v7,
and v9). The same consistent results are shown in the skipping
of exon 9 event in rat samples, with low levels in brain
observed by both approaches.
Discussion
In this study, we have deeply characterized a high number of
alternative splice variants of RAGE in different mammals and
tissues, and we have compared their relative expression levels.
A diversity of functions of RAGE has been previously described
as a result of AS events (Yonekura et al. 2003; Hudson et al.
2008; Kalea et al. 2009; Sterenczak et al. 2009), which can
modify protein domains. Previous studies focused on splice
variants of RAGE in human (Hudson et al. 2008) and mouse
(Kalea et al. 2009) showed similar results in expression levels of
each splice variant. In human, RAGE had only been studied in
detail in lung and aortic smooth muscle cells (AoSMCs)
(Hudson et al. 2008). Comparison of adult lung in previous
(Hudson et al. 2008) and our studies show similar expression
levels for Tv1-RAGE (80% and high expression levels, respec-
tively) and different for Tv6-RAGE (C-truncated) (7% and
moderate expression levels, respectively). Interestingly, in our
study adult and fetal lung were the only two tissues showing
these two isoforms, whereas tumor lung presents a high
number of different splice variants.
Previous studies related to RAGE splice variants in different
mouse tissues have been performed (Harashima et al. 2006;
Kalea et al. 2009). Harashima et al. (2006) identified a soluble
isoform on brain using nested PCR, and the relative abun-
dance among other tissues and isoforms was quantified
using a small PCR (exons 9–11) so these cannot be compared
with our results. In that work, they also describe a soluble
isoform (esRAGE) not found in our study, but they generated
it with a primer in the second round of PCR specific to the
intron 9 retained. In the study by Kalea et al. (2009), murine
lung tissue showed both Tv1-RAGE (53%) and mRAGE_v4
(41%) expressions, and we have found high expression and
low expression, respectively. The smaller isoforms they found
are different from those described here, but they also detected
them at very low expression levels (1% in each splice variant).
In general, our results are somewhat consistent with previous
studies (Hudson et al. 2008; Kalea et al. 2009) as percentages
higher than 50% are related to our high expression levels,
50–40% to moderate–high, and 40–20% to low, in most
cases. Lower than 20% is sometimes not detected in our
study, and, on the other hand, low-expression variants
detected by us were not detected by them. In both human
and mouse previous studies (Hudson et al. 2008; Kalea et al.
2009), the splice variants were analyzed by RT-PCR and
restriction enzyme recognition sequences, whereas we sepa-
rated the RT-PCR product electrophoretically, cloned and ver-
ified by sequencing. Both approaches use nested PCR, by
reason of the extremely low expression levels of RAGE,
which makes it impossible to approach the study in the dy-
namic PCR range. Therefore, this methodology could slightly
influence the findings limiting the power to differentiate splice
variants expression and their relative abundance. For this
reason, low-expression variants, which are the most difficult
to detect, sometimes showed differences among these stud-
ies. Indeed, the optimal approach for determining the relative
expression of each transcript should be a quantitative RT-PCR
(qRT-PCR). However, because of the presence of multiple
splice events common to several isoforms is completely impos-
sible to design a qRT-PCR assay to discriminate one against
each other. Nevertheless, this technique was used in canine
RAGE (Sterenczak et al. 2009) to describe splice variants in
healthy and tumor tissues, but these analyses were performed
only with the intron 1 retention event. They detected high
expression levels of intron 1 retained variants in neoplastic
samples. On the other hand, intron 1 skipping was appointed
to healthy transcript variants and, therefore, with lower ex-
pression levels of the intron 1 retention event in healthy tissues
(Sterenczak et al. 2009). This assay was performed as a global
effect of the intron 1, not trying to discriminate among the
different variants. The wide diversity of intron 1 retention
splice variants that we found cannot be differentiated against
each other with that assay and, for this reason, in our study,
we find splice variants with intron 1 retention that are highly
expressed in healthy adult and fetal tissues, and intron 1 skip-
ping splice variants also present in tumor tissues with different
expression levels.
Nowadays, the high-throughput sequencing technology is
being employed to describe the complete transcriptome of
several organisms (Barbosa-Morais et al. 2012; Merkin et al.
2012; Rastrojo et al. 2013). This technique provides informa-
tion on differential expression of genes, posttranscriptional
mutations or edition, and gene fusions, among others.
Furthermore, differences in transcript expression levels
should also be observed, but sufficient coverage is required.
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In the case of RAGE, both low expression and high transcrip-
tomic complexity made extremely difficult to approach
the transcriptomic study by this technology. Indeed, in the
sample used with high coverage (human monocytes, with
200 millions of paired reads), we were able to detect only
three of the splice variants detected by nested PCR, and
only when Cufflinks parameters were altered. For these
reasons, particular detailed transcriptional studies of low
expression genes such as RAGE could be misinterpreted by
high-throughput sequencing technologies, and it would be
better to study them by other techniques like the one we
use in this study.
The transcript variants found and their common splice
events could have potential regulatory functions about the
overall role of the Tv1-RAGE isoform, and could be involved
in the development of several diseases including cancer or
Alzheimer’s disease, among others. For instance, low levels
of circulating sRAGE have been associated with an increased
risk of Alzheimer’s disease (Emanuele et al. 2005), diabetic
complications (Grossin et al. 2008), cardiovascular disease
(Falcone et al. 2005), and hypertension (Geroldi et al. 2005)
in humans. Removal of the transmembrane region allows
the generation of sRAGE isoforms by different biological
processes. These soluble variants (sRAGE) found in humans
are due to either alternative splicing (esRAGE) or proteolytic
cleavage (Maillard-Lefebvre et al. 2009) of carboxyl-terminal
truncation of membrane-bound isoforms (cRAGE) (Hanford
et al. 2004) by the sheddase ADAM10 (Raucci et al. 2008).
Adult rat sRAGE shows high protein expression levels, 2-fold
higher compared with neonatal rat (Lizotte et al. 2007)
and then, proteolytic cleavage of the membrane-bound
isoforms seems to be the main way of sRAGE generation
(Hanford et al. 2004). To conclude, any of these biological
events could generate soluble receptors of RAGE which
could bind to ligands before they find membrane-bound
receptor RAGE, and thereby attenuate intracellular RAGE
signaling. We have been able to detect potential soluble
isoforms in all the analyzed species, although only in human
(Tv4-RAGE and Tv6-RAGE) and mouse (MmusRAGEv4)
they contain the three Ig domains and a signal peptide.
Interestingly, all species except rat present soluble isoforms
with only the first two Ig domains, which are the ones involved
in ligand binding.
Furthermore, we have found splicing events resulting in
changes in the extracellular domain that may affect the
ligand binding domain, by insertion, deletion, or removal of
partial Ig-V domain of RAGE. Binding of AGEs (Grossin et al.
2009) or Ab peptides (Ding and Keller 2005a) to the Ig-V
domain in the membrane-bound receptor RAGE has been
suggested to contribute to the pathogenesis of diabetic
vascular complications and Alzheimer’s disease, respectively.
Ig-V domain modification could generate changes in ligand
affinity of RAGE, and splice variants with these domains mod-
ifications could be important factors in disease modulation.
Indeed, there are several variants that lack the signal peptide,
and hence, their specific intracellular transport and structure
could be altered. This sort of regulation could modify the final
location of each isoform and, therefore, its specific function.
Furthermore, most of these splice variants have a PSC and
they should be degraded quickly by nonsense-mediated
decay. However, they seem to be stable, as it has been
shown by other studies (Hudson et al. 2008; Kalea et al.
2009) and our case, finding them to be relatively abundant.
The only two variants that are found in all the analyzed species
are the equivalent isoforms to human Tv1-RAGE and Tv10-
RAGE (table 1), which are also the most abundant ones. In
fact, Tv10-RAGE presents a PSC but is even more expressed
than Tv1-RAGE in some species (Artiodactyla group). This is
very interesting from the evolutionary point of view of the
conservation of the highly and widely expressed Tv10-RAGE
variant in tissues and species, which can be related to gener-
ation of a new function. In human, monkey, and pig samples,
the predicted protein lacks the first IgV domain, whereas in
cow and rat samples, it would also encode the first IgV
domain, although it has to be considered that they do not
contain a signal peptide. In addition, this Tv10-RAGE is a pre-
dicted noncoding variant in mouse.
On the other hand, other splice variants of RAGE were
shown in previous studies, such as dominant-negative RAGE
(dnRAGE or RAGE), which only lacks 16 amino acids of the
intracellular domain (Ding and Keller 2005a). These splice var-
iants can bind to Ab ligand and thereby also prevent RAGE
signaling. But neither our study nor previous related studies
(Yonekura et al. 2003; Hudson et al. 2008; Kalea et al. 2009;
Sterenczak et al. 2009) have found these dnRAGE variants,
therefore dnRAGE could be tissue or disease specific. We have
not detected any other alterations on the cytoplasmic tail in
any of the analyzed mammals.
There are also novel transcripts of unknown function,
which are mainly long and small ncRNAs. Intron retention is
the common splice event in potential long ncRNAs, whereas
large exon skipping generates the potential small ones.
Previous studies related to ncRNAs show noncoding genes,
such as XIST (Duret et al. 2006) or HOTAIR (Rinn et al.
2007), but not much is known about coding genes with
alternative noncoding splice variants, as we show in this
study. This event could significantly increase the number of
ncRNAs among wide RNAs. Moreover, these ncRNAs may
underlie vital intracellular functions, such as transcriptional
regulation or epigenetics among others (Kikuchi et al. 2009;
Marques and Ponting 2009; Ponting et al. 2009), being
generated from individual transcript or multiple rounds of
cleavage of a unique loci (Tuck and Tollervey 2011). In this
particular case, the presence of these different noncoding
variants could be to regulate the full-length RAGE isoform
and/or its functions in each specific tissue. Because of that,
long and small noncoding RAGE variants seem to be involved
in different processes, since long ncRNAs show wide
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expression among the different tissues and, by contrast, small
ncRNAs only had low expression and very specific distribution.
Furthermore, we have also observed that most of the ncRNAs
detected in our study seem to be species-specific splice vari-
ants and only a few of them are conserved among the ana-
lyzed mammals. These nonconserved variants could be due
to transcriptional noise corresponding to the phenomenon
described as noisy splicing (Baek and Green 2005; Zhang
et al. 2007, 2009; Melamud and Moult 2009; Pickrell et al.
2010) as it is associated to lowly expressed genes and splice
junctions not conserved in different tissues nor in species.
Some authors have mentioned the implication of noisy splicing
as an important property of genome evolution (Pickrell et al.
2010). Nevertheless, to further characterize this, it would
require increasing the number of tissues analyzed in each
species to fully determine the species specificity of each
splice variant. Either different distribution or species-specific
noncoding RAGE variants could generate a wide diversity of
functional roles that remain still unknown.
Conclusions
In conclusion, we provide evidence that RAGE undergoes ex-
tensive AS in the six analyzed mammalian species, generating
different isoforms which are distributed among tissues (fetal,
adult, and tumor samples) and species (human, monkey, cow,
pig, mouse, and rat). No such detailed analysis, which com-
pares a complex alternative spliced gene in different species
and tissues, has been previously performed. These transcripts
have been detected through direct RT-PCR amplifications and
sequencing of the products but not by RNA-seq using default
Cufflinks parameters although a very few can be detected
after altering them. In summary, we can classify these
transcripts in: highly expressed conserved splice variants; low
but stable expressed, less or not conserved variants; and lowly
expressed, in only one or two conditions, species-specific
variants. Comparison between the splice variants in these
mammals reveals only two totally conserved ones (human
TV1-RAGE and TV10-RAGE and their homologs) indicating a
special evolution pattern at the mRNA level. This is interesting
from the point of view of different biological functions of one
particular gene among different species and, in particular,
when they are used as animal models. Furthermore, a large
majority of these variants are predicted as noncoding isoforms
with unknown function, more than previously known. In fact,
Tv10-RAGE and homologs could be a noncoding variant that
is highly and broadly expressed. After this analysis, we have
observed an even more complex and tissue-specific AS
variants than expected among mammals, including a great
variability of coding and noncoding variants. For this reason,
further extensive studies of functionally relevance of each
splice variant are necessary to understand the overall role of
RAGE biology, and their possible implication among diseases
and evolution. Indeed, similar studies should be performed
with other genes to evaluate whether complex AS patterns
are common.
Supplementary Material
Supplementary figures S1–S3 and tables S1 and S2 are avail-
able at Genome Biology and Evolution online (http://www.
gbe.oxfordjournals.org/).
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